Lightbridge Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2016

Average risk-free interest rate	0.83	%
Average expected life- years	3.39
Expected volatility	92.61
Expected dividends	0	%

Schedule of Future Amortization of Deferred Financing Costs

2016	$	0.1
2017	$	0.5
2018	$	0.5
2019	$	0.5

Schedule of Warrants Outstanding

	September 30,		December 31,
	2016		2015
Issued to Investors on July 28, 2010, entitling the holders to purchase 207,000 common shares in the Company at an exercise price of $45.00 per common share up to and including July 27, 2017. These warrants are reported in the liability section of our balance sheet.		207,000		207,000

Issued to Investors on October 25, 2013, entitling the holders to purchase 250,000 common shares in the Company at an exercise price of $11.50 per common share up to and including April 24, 2021. These warrants are reported in the liability section of our balance sheet.		223,436		223,436

Issued to Investors on November 17, 2014, entitling the holders to purchase 546,919 common shares in the Company at an exercise price of $11.55 per common share up to and including May 16, 2022 - reclassified to equity on June 30, 2016, exercise price amended to $6.25 per common share. These warrants are reported in the equity section of our balance sheet on September 30, 2016 and in the liability section of our balance sheet on December 31, 2015.		546,919		546,919

Issued to an Investor on June 28, 2016, entitling the holders to purchase 295,267 common shares in the Company at an exercise price of $0.05 per common share (pre-funded) up to and including June 27, 2021. These warrants are reported in the equity section of our balance sheet.		295,267		-

Issued to an investor on August 10, 2016, entitling the holders to purchase 500,000 common shares in the Company at an exercise price of price of $0.01 per share, up to and including December 31, 2019. These warrants are reported in the equity section of our balance sheet.		500,000		-

		1,772,622		977,355

Schedule of Share-based Compensation, Stock Options, Activity

Stock option transactions to the employees, directors and consultants are summarized as follows for the nine months ended September 30, 2016:

	Options Outstanding			Weighted Average Exercise Price		Weighted Average Grant Date Fair Value
Beginning of the period		1,047,450		$	18.50	$	20.30
Granted		483,079			4.71		2.83
Exercised		-			-		-
Forfeited		(78,668	)		101.57		101.02
Expired		-			-		-
End of the period		1,451,861		$	9.41	$	7.03

Options exercisable		756,162		$	13.36	$	10.31

Stock option transactions to the employees, directors and consultants are summarized as follows for the year ended December 31, 2015:

	Options Outstanding			Weighted Average Exercise Price		Weighted Average Grant Date Fair Value
Beginning of the year		405,344		$	45.95	$	53.05
Granted		698,323			5.40		3.70
Exercised		-			-		-
Forfeited		(22,883	)		33.15		30.30
Expired		(33,334	)		67.50		64.20
End of the year		1,047,450		$	18.50	$	20.30

Options exercisable		688,452		$	24.75	$	8.40

Schedule of Non-Vested Shares, Activity

	Shares			Weighted- Average Fair Value Grant Date		Weighted Average Exercise Price
Non-vested Shares
Non-vested at January 1, 2015		92,467		$	8.55	$	12.75
Granted		698,323			3.70		5.40
Vested		(431,789	)		4.00		5.90
Forfeited		-			-		-
Non-vested - December 31, 2015		359,001		$	4.55	$	6.70

Granted		483,079		$	2.83	$	4.71
Vested		(146,381	)		3.76		7.27
Forfeited		-			-		-
Non-vested - September 30, 2016		695,699		$	3.45	$	5.12

Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

The following table provides certain information with respect to the above-referenced stock options that are outstanding and exercisable at September 30, 2016:

	Stock Options Outstanding						Stock Options Vested
	Weighted						Weighted
	Average						Average
	Remaining				Weighted		Remaining				Weighted
	Contractual		Number		Average		Contractual		Number		Average
	Life		of		Exercise		Life		of		Exercise
Exercise Prices		-Years	Awards		Price			-Years	Awards		Price

$1.74-$4.50		6.90		9,993	$	3.25		6.90		9,993	$	3.25
$4.51-$6.00		9.14		812,033	$	4.60		9.14		227,318	$	4.60
$6.01-$20.00		6.75		451,843	$	7.61		6.64		340,849	$	7.53
$20.01-$45.00		2.49		144,683	$	31.47		2.49		144,683	$	31.47
$45.01-$73.50		0.95		33,309	$	57.13		0.95		33,309	$	57.13
Total		7.53		1,451,861	$	9.41		6.35		756,162	$	13.36

The following table provides certain information with respect to the above-referenced stock options that are outstanding and exercisable at December 31, 2015:

	Stock Options Outstanding						Stock Options Vested
	Weighted						Weighted
	Average						Average
	Remaining				Weighted		Remaining				Weighted
	Contractual		Number		Average		Contractual		Number		Average
	Life		of		Exercise		Life		of		Exercise
Exercise Prices		-Years	Awards		Price			-Years	Awards		Price

$4.15-$6.30		9.70		698,323	$	5.38		9.58		393,145	$	5.31
$12.75-$25.00		3.26		129,141	$	15.52		3.20		75,321	$	17.50
$25.05-$64.50		3.04		133,648	$	37.93		3.04		133,648	$	37.93
$67.50-$94.50		0.63		38,338	$	73.77		0.63		38,338	$	73.77
$96.00-$119.25		0.12		48,000	$	119.25		0.12		48,000	$	119.25
Total		7.28		1,047,450	$	18.50		6.46		688,452	$	24.75

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

	Nine months ended			Year ended
	September 30,			December 31,
	2016			2015

Average risk-free interest rate		1.69	%		1.64	%
Average expected life- years		5.5			5.38
Expected volatility		86.63	%		86.66	%
Expected dividends	$	0.0		$	0.0

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details